The clinical course in most cases was irregular. Complications were common, the most important being cerebral oedema with medullary coning, bleeding, bacterial infection, hypoglycaemia, and pancreatitis.
The development of coma in the course of acute viral hepatitis has a grave prognosis since it usually indicates extensive liver cell damage. However, the condition is potentially reversible, and a number of supportive measures have been advocated in an effort to maintain life until sufficient hepatic regeneration can occur to permit an unaided recovery (Benhamou, Rueff, and Sicot, 1968) . This paper describes our experience in the management of 17 patients with viral hepatitis who developed coma unresponsive to standard conservative measures. Initially exchange transfusion was used, but after disappointing results a trial of heterologous liver perfusion was begun.
PATIENTS AND METHODS
There were 10 female and seven male patients aged 5 to 56 years (Tables I to III) . They were seen during a period of 30 months, during which time 1,040 patients were admitted to the Prince Henry Hospital with a diagnosis of viral hepatitis, and 20 of these patients died. The diagnosis was based on the clinical course and the absence of other known causes of acute hepatic failure.
The grading of coma was that used by the Fulminant Hepatic Failure Surveillance Study (Trey and Organizing Group, 1968) and can be summarized as follows: grade I is mood change and mild confusion; grade II drowsy; 898 grade [II stuporose; and grade IV unrousable, except possibly by noxious stimuli. All patients treated by exchange transfusion or liver perfusion had grade [II or lV coma at the start of the procedure. All patients had clinical evidence of a haemorrhagic diathesis; the one-stage (Quick) prothrombin times ranged from 25 to 180 seconds (control 12 to 16 seconds). Hypokalaemia and hypoglycaemia, if present, had been corrected for at least 12 hours before exchange transfusion or liver perfusion.
The clinical course in most patients was one of overall progressive clinical deterioration, but with transient fluctuations in conscious state. Such fluctuations could not always be related to changes in therapy or to obvious complications of hepatic failure. (Table IV) . Infusion and withdrawal were performed simultaneously. The rate of exchange of each litre of blood varied from 40 to 120 minutes, and the volume of blood used for each exchange ranged from 2-5 to 8 litres. At the end of each procedure, protamine, fibrinogen, or fresh-frozen plasma were given as indicated by tests of coagulation.
HETEROLOGOUS LIVER PERFUSION Nine patients were considered for treatment by liver perfusion (Table II) . Three patients (nos. 9, 11, and 14) had oliguric renal failure. The liver was clinically reduced in size in all except nos. 7 and 13. The serum bilirubin ranged from 20-4 to 40.0 mg/100 ml and the serum alanine aminotransferase from 55 to 948 IU/litre. Two patients (nos. 9 and 11) were rejected because coma appeared to be principally due to renal failure. A third patient (no. 10) died from haemorrhagic shock (probably due to pancreatitis) while a pig's liver was being prepared.
The techniques for the liver perfusions have been described in detail previously (Ham, Pirola, Davidson, Yarrow, and Elmslie, 1968) . The livers were excised from pigs weighing 20 to 30 kg after having been cooled and washed free of pig's blood. Each liver was then perfused in an isolated circuit with a heat exchanger and an oxygenator. The circuit was primed with blood compatible with that of the patient. The liver was warmed to 38°C and optimal liver blood flow and portal venous pressure were established. When the perfusion was stable and bile was flowing, the circuit was connected to the patient via an arteriovenous shunt in the brachial vessels. If the blood flow obtained from the brachial artery was less than that necessary to maintain liver blood flow, then the flow was supplemented by recirculation through the oxygenator (Fig. 1 (Table II) , haemodialysis was performed for six hours with a Kolff twin-coil machine and the dialysate was changed two hourly. The effect of the addition of albumin to the dialysate on the removal of bilirubin was tested in these patients. In the peritoneal dialyses, albumin was added to two or more consecutive changes to give concentrations of 2-0 to 5-2 g/100 ml. In the haemodialysis, albumin was added to the second dialysis to give a concentration of 3 g/100 ml. The bilirubin concentration in the serum and in the dialysate was measured before, during, and after the addition of albumin.
RESULTS
EXCHANGE TRANSFUSION Two patients showed a transient improvement (Table IV) . In one (no. 3), the grade of coma improved from IV to II after the first exchange. There was no improvement with the second exchange and she died shortly afterwards from massive gastrointestinal haemorrhage. In the second patient (no. 4), the coma lightened from grade III to grade II after each of the first two exchanges, but no improvement was seen following the remaining two. He developed bronchopneumonia, and died. The remaining two patients showed no improvement and died shortly after the procedure. One of these (no. 2) had cerebral oedema with medullary coning at necropsy. In no patient was there any significant improvement in the electroencephalogram following the procedure. Each exchange produced a sharp fall in the serum bilirubin concentration. This was followed by an equally sharp rebound, and in most instances the concentration returned to the pre-exchange value within 24 hours (Table IV) . (Harris, 1968) . Treatment with azathioprine was associated with a complete remission, and he remains well nine months later.
The remaining patients died. One (no. 12) improved with each of the first two perfusions (grade IV to II and grade IV to III), and became so restless with the first treatment that light anaesthesia with nitrous oxide was necessary. There was no improvement with the third perfusion. The first perfusion in two other patients (nos. 6 and 13) also produced lightening of the coma. However, subsequent perfusions in these patients, and those performed in the remaining two patients (nos. 8 and 14), had no obvious effect. (Table III). In no case did dialysis produce any   2   3   2   6   7  8  12   13   14   240  300  240  180  60  53  120  180  195  120   IV  Iv  IV  IV  III  IV  IV  IV  iV  IV group.bmj.com on June 24, 2017 -Published by http://gut.bmj.com/ Downloaded from obvious clinical improvement or any change in the serum bilirubin level.
DISCUSSION
The patients described in this report developed a variety of severe complications. These included cerebral oedema, bleeding, bacterial infection, hypoglycaemia, and pancreatitis. Thus, the course of the illness in these patients was very irregular, adding to the problems of timing and assessment of therapy. Cerebral oedema with medullary coning is not a recognized complication of hepatic failure, but has been reported in association with viral hepatitis (Lucke, 1944) . It was the immediate cause of death in at least two patients reported here (nos. 2 and 5) and probably also occurred in a third (no. 6). A fourth patient (no. 15) had severe cerebral oedema without medullary coning.
Disorders of blood coagulation are a major clinical problem in hepatic failure and may be further aggravated by exchange transfusion or liver perfusion. Bleeding was a major factor contributing to the death of two of the present patients (nos. 3 and 8). We feel it is important to minimize the risk of inducing bleeding by avoiding percutaneous puncture of large vessels and suction on nasogastric tubes.
Hypoglycaemia occurred in one of the present patients (no. 13) and may have been present for some hours before it was recognized. Subsequently large doses of glucose were required to maintain an adequate concentration in the blood. In this patient, brain damage due to hypoglycaemia may have prevented clinical improvement during perfusion.
Acute pancreatitis is a recognized but uncommon complication of infectious hepatitis (Achord, 1968) . Haemorrhagic pancreatitis was found at necropsy in two of our patients; in one (no. 10) it appeared to be a major factor contributing to death. Some degree of renal dysfunction was present in most of the patients reported here. However, dialysis in four patients had no influence on the patients' coma, and the addition of albumin to the dialysate did not improve the removal of bilirubin. The level of bilirubin in the serum may be of little direct importance in hepatic coma. However, its removal is of interest since it is a protein-bound substance normally removed by the liver and it has been suggested that hepatic coma may result from the accumulation of protein-bound 'toxic' substances (Jones, Clain, Clink, MacGillivray, and Sherlock, 1967) .
The assessment of therapy for hepatic failure complicating acute liver disease is difficult for other reasons apart from the unpredictable course of the illness. These include lack of knowledge of the mechanisms responsible for coma, the relatively small number of patients seen by any one unit, and the absence of a biochemical test that correlates reliably with the degree of hepatic coma or with the severity of liver cell damage. The difficulties in assessing therapy are exemplified by the contrasting claims made for a variety of supportive measures used in hepatic failure (Benhamou et al, 1968) . There is a need for combined studies, provided that uniform methods for assessing patients can be defined.
In the present study, all patients had presumed viral hepatitis, and all had deepening coma despite a full trial of standard conservative treatment; a fatal outcome was expected in each. The transient improvements in patients nos. 3, 4, 6, 12, and 13, and the full recovery in patient no. 7, are therefore encouraging. In the latter patient, there were three favourable prognostic points, namely, hepatomegaly, a serum bilirubin of only 21.3 mg/100 ml, and a high serum alanine aminotransferase (850 IU/litre). Most patients had small livers at the time of the first exchange transfusion or liver perfusion, although two (nos. 7 and 13) had enlarged livers which subsequently shrank in size. In the surviving patient, the serum bilirubin was lower, and the serum alanine aminotransferase higher, than in most of the other patients. On the other hand, the serum alanine aminotransferase had fallen by 300 IU/litre in the 24 hours before liver perfusion. In our experience, such a fall, combined with a rising serum bilirubin concentration and deepening coma, is almost inevitably fatal.
In this patient, liver biopsy one month after perfusion showed that there was still extensive hepatocellular damage, but there was only minimal periportal fibrosis. A second biopsy six months later showed no increase in the fibrosis. In the necropsies on fatal cases the degree of hepatic damage was variable, but in all cases was severe and associated with a distorted architecture. It would appear that some degree of cirrhosis would have been inevitable if these patients had survived.
The variety of complications seen in severe viral hepatitis, and the consequently irregular course of the illness, make it impossible for any one unit to have sufficient patients to carry out a controlled trial of new forms of therapy. In the absence of controls the selection of patients is critical. The method of selection of patients for exchange transfusion and liver perfusion in this study was such that a high percentage of survivals would have been a strong indication that the special therapeutic measures used had been effective. Such a cautious approach seemed to be particularly indicated in the application of a new technique such as liver perfusion. However, this method of selection created further problems. In some patients deterioration was so rapid that at the start of liver perfusion there were already intermittent episodes when electrical activity was absent from the electroencephalogram. In view of this, and of the low incidence of major complications from the special procedures used, it would seem desirable to start the procedures earlier.
The present results suggest that both methods have some effect on the course of the illness. However, the data are inadequate to distinguish which method is the better except that liver perfusion was more efficient in the removal of bilirubin.
